Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
If you find passwords frustrating, two-factor authentication probably won’t get much love. But security experts say using two-factor authentication is one of the best ways to protect your online ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results